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ABSTRACT. Cerebral ischemia and symptoms of
stroke can occur as a rare manifestation in pa-
tients with pheochromocytoma. We describe a
45-year-old woman who was admitted because
of a right-sided hemiparesis due to an ischemic
lesion in the left hypothalamus. The clinical di-
agnosis of a pheochromocytoma was proven by
highly elevated urinary catecholamines and con-
firmed histologically after operation. The suc-
cessful removal of the tumor led to the almost
complete recovery of the neurological deficien-
cies. It is of vital importance to know this atypi-
cal presentation of pheochromocytoma. The di-
agnosis of pheochromocytoma should be sus-
pected in patients with focal cerebral symptoms,
particularly in the presence of intermittent hy-
pertension or other paroxysmal symptoms sug-
gestive of pheochromocytoma.
(J. Endocrinol. Invest. 22: 212-214, 1999)
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INTRODUCTION
Pheochromocytoma is a rare tumour which occurs
approximately in 0.13% of the general population
(1). The typical manifestations of pheochromocy-
toma are paroxysmal or sustained hypertension
with sudden attacks of sweating, palpitations,
tremor and headache (2). Neurological symptoms in
patients with pheochromocytoma have been re-
ported (3). Reversible cerebral ischemia with focal
neurological deficiencies is a rare manifestation of
pheochromocytoma. We observed a patient with
neurological defects as presenting symptoms of a
phaeochromocytoma.
CASE REPORT 
A 45-year-old woman was admitted because of a
gradual onset of right-sided hemiparesis. On neu-
rological examination the patient was alert and ori-
ented, but she had a sensomotoric hemiparesis,
which affected mainly the upper limb. We observed
a central facial palsy as well as hyperreflexia and a
positive sign of Babinski on the right side. On ad-
mission the blood pressure was normal (120/70
mmHg) with no history of hypertension. The CT
scan revealed a small hypodense lesion in the left
hypothalamus. Extensive diagnostic evaluation
failed to show a cause for this lesion except a ven-
tricular arrythmia, Lown grade IVa. A therapy with
sotalol 160 mg daily was begun. The patient re-
covered and left the hospital after 17 days. On dis-
charge, all motor deficiencies had resolved and the
patient showed only slight numbness and dysmetria
of her right arm. These symptoms persisted in the
long-term follow-up.
At home, repeated attacks of sweating, dizziness,
nausea and one syncope occurred under sotalol
and she was readmitted to the intensive care unit.
This was the first time, when symptoms suggesting
catecholamine hypersecretion were present. A pro-
longed QT interval was observed and an episode of
torsade de pointes with consecutive ventricular fib-
rillation occurred. After resuscitation a blood pres-
sure of 260/159 mmHg was measured. The diag-
nosis of a pheochromocytoma was established by
the detection of very high levels of urinary cate-
cholamines: Norepinephrine 16,165 nmol/die (nor-
mal up to 10) and epinephrine 4308 nmol/die (nor-
mal up to 110) and a right-sided, large adrenal mass
of 8x10 cm in the CT scan (Fig. 1). Preoperative
adrenergic blockade was established by phenoxy-
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benzamine and propranolol for 10 days. An anteri-
or transabdominal approach was first performed to
remove the tumour. However, the upper pole of
the pheochromocytoma could not be detached ad-
equately and an additional transthoracic approach
was necessary. Manipulation of the tumor induced
acute hypertension, that could be effectively treat-
ed by sodium nitroprusside and phentolamin. The
tumor could be removed successfully and the his-
tological examination confirmed the clinical diag-
nosis of a benign pheochromocytoma of 600 g
weight.
DISCUSSION
The clinical presentation of our patient is unusual be-
cause of the neurological presenting symptoms lead-
ing to hospital admission and because the neuro-
logical symptoms were almost completely reversible. 
Only few reports exist about the occurrence of an
ischemic cerebral infarction in patients with pheo-
chromocytoma (1, 3). Some of them were at least
partially reversible. Thomas et al. described tran-
sient neurological symptoms in 11 and cerebral in-
farctions in 3 of 100 patients with pheochromocy-
toma (4).
There are several reasons for the onset of an acute
ischemic cerebral infarction in patients with pheo-
chromocytoma. Hypertension alone can result in cere-
bral infarction in patients with pheochromocytoma as
published recently by Goswami et al. (5). Hyper-
tensive encephalopathy may be caused by a failure of
cerebral vessel autoregulation with very high blood
pressure values and can occur with a single crisis of
hypertension without chronic hypertension (3). In our
patient, the paroxysmal hypertension was observed
only after treatment with sotalol was introduced. The
paradoxical rise in blood pressure in patients with
pheochromocytoma may supervene with adminis-
tration of β-blockers, revealing unopposed α-adreno-
receptor stimulation. However, the pathological
changes of hypertensive encephalopathy consist of
widespread small areas of ischemic injury and are not
restricted to the distribution of single vessels (3, 5). A
paroxysm of hypertension may be followed by pro-
longed hypotension due to systemic exhaustion of
catecholamines (3). Systemic hypotension produces
either widespread microscopic lesions or larger in-
farctions in the cerebral border zones (3).
The brain lesions may have been caused by spasms
of the cerebral arteries, since vascular spasms in pe-
ripheral, coronary and cerebral arteries have been
induced with sympathomimetic agents (6) and have
also been reported in patients with pheochromo-
cytoma (3, 7). Spasm produces either transient im-
pairment of circulation or infarction (8). Cerebral va-
sospasm can be induced either by excessive cate-
cholamines (5) or by other secretory products of the
adrenal tumor, such as neuropeptide Y, renin, en-
dothelin or angiotensin-converting enzyme (9).
These substances are not only vasoactive but can
also promote platelet aggregation (10, 11). 
Cerebral ischemia and symptoms of stroke can oc-
cur as presenting features in some patients with
pheochromocytoma. It is of vital importance to
know this atypical presentation and to establish ear-
ly diagnosis in order to avoid irreversible neuro-
logical damage or death in such patients. We con-
clude that the diagnosis of pheochromocytoma
should always be suspected in patients with focal
cerebral symptoms, particularly in the presence of
intermittent hypertension or other paroxysmal
symptoms suggestive of pheochromocytoma. 
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